US8618286, 15

ID: ALA3675243

PubChem CID: 44600243

Max Phase: Preclinical

Molecular Formula: C19H26N4S2

Molecular Weight: 374.58

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(CC)CCN1CCSc2cc(/N=C(\N)c3cccs3)ccc21

Standard InChI:  InChI=1S/C19H26N4S2/c1-3-22(4-2)9-10-23-11-13-25-18-14-15(7-8-16(18)23)21-19(20)17-6-5-12-24-17/h5-8,12,14H,3-4,9-11,13H2,1-2H3,(H2,20,21)

Standard InChI Key:  KVJVXERVBNBTLK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    7.5395   -1.3388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4990   -0.7409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2003   -1.4932    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1998   -2.9940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1608   -3.5944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8990   -0.7455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6003   -1.4977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990   -0.7500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    0.7500    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5981   -3.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -3.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -3.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8963   -3.7531    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8941   -5.2539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8539   -5.8521    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1923   -6.0070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3302   -7.4879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7974   -7.7998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5474   -6.5007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5437   -5.3860    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  8  1  0
 17 12  1  0
 14 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 21  1  0
M  END

Associated Targets(Human)

NOS3 Tchem Nitric-oxide synthase, endothelial (1452 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NOS1 Tchem Nitric-oxide synthase, brain (1786 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NOS2 Tchem Nitric oxide synthase, inducible (1636 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 374.58Molecular Weight (Monoisotopic): 374.1599AlogP: 4.04#Rotatable Bonds: 7
Polar Surface Area: 44.86Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.51CX LogP: 3.89CX LogD: 0.62
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.59Np Likeness Score: -1.94

References

1.  (2013)  Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity, 

Source

Source(1):